Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Cancer and Metastasis Reviews

Issue 4/2008

Special issue: Imaging of Molecular Pathways Associated with Cancer, Guest Editor: Anthony F. Shields

Content (16 Articles)

Biography - Anthony F. Shields, M.D., Ph.D.

Preface-imaging in cancer

Anthony F. Shields

Imaging of tumor glucose utilization with positron emission tomography

Andrea Buerkle, Wolfgang A. Weber

Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography

Jonathan McConathy, Mark M. Goodman

The role of DNA synthesis imaging in cancer in the era of targeted therapeutics

Sridhar Nimmagadda, Anthony F. Shields

Imaging hemodynamics

Dominique Jennings, Natarajan Raghunand, Robert J. Gillies

Non-invasive assessment of tumor neovasculature: techniques and clinical applications

Rodolfo Perini, Regine Choe, Arjun G. Yodh, Chandra Sehgal, Chaitanya R. Divgi, Mark A. Rosen

Imaging of integrin αvβ3 expression

Ambros J. Beer, Markus Schwaiger

Molecular imaging of epidermal growth factor receptor expression–activity at the kinase level in tumors with positron emission tomography

Juri G. Gelovani

Tumor detection using folate receptor-targeted imaging agents

Emanuela I. Sega, Philip S. Low

Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children

M. Sue O’Dorisio, Geetika Khanna, David Bushnell

Imaging matrix metalloproteinases in cancer

Randy L. Scherer, J. Oliver McIntyre, Lynn M. Matrisian

NON-THEMATIC REVIEW

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

Osvaldo L. Podhajcer, Lorena Gabriela Benedetti, Maria Romina Girotti, Federico Prada, Edgardo Salvatierra, Andrea S. Llera

NON-THEMATIC REVIEW

Cell cycle control and adhesion signaling pathways in the development of metastatic melanoma

A. V. Danilov, O. V. Danilova, B. T. Huber

NON-THEMATIC REVIEW

Caveolin-1 in tumor progression: the good, the bad and the ugly

Jacky G. Goetz, Patrick Lajoie, Sam M. Wiseman, Ivan R. Nabi

NON-THEMATIC REVIEW

Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents

Nicolas Magné, Cyrus Chargari, Eric Deutsch, Pierre Castadot, Mitra Ghalibafian, Jean Bourhis, Christine Haie-Meder

Sep 08
Issue: 3/2008
Special issue: Biomarkers of Clinical Trials Using Molecular Inhibitors and Radiotherapy: State-of-the-Art Approaches, Guest Editor: Robert G. Bristow
Jun 09
Issue: 1-2/2009
Special issue: Cytoskeleton Signaling in Cancer, Guest Editors: Rakesh Kumar and Alan Hall

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits